The International Journal of Biopharmaceutical Manufacturing and Therapeutic Advances (IJBMTA) is a multidisciplinary, peer-reviewed journal devoted to promoting excellence in research, innovation, and practical application within the realms of biopharmaceutical production, formulation development, and advanced therapeutic technologies.
IJBMTA provides a scholarly forum for the global exchange of knowledge and ideas between academic researchers, biopharmaceutical engineers, industry professionals, and regulatory experts involved in the development and manufacturing of biologics and therapeutic agents.
Our Mission
Our mission is to accelerate scientific discovery and technological advancements in the field of biopharmaceuticals by:
- Publishing high-quality, evidence-based research
- Supporting innovation in therapeutic production and delivery
- Fostering collaboration between academic and industrial stakeholders
- Promoting regulatory compliance and global standards in manufacturing
- Enabling access to reliable scientific data through open-access publishing
Scope of the Journal
The journal covers a broad range of topics, including but not limited to:
- Biomanufacturing processes and scale-up technologies
- Upstream and downstream processing of biologics
- Formulation, stability, and delivery of therapeutic proteins and peptides
- Biosimilars, monoclonal antibodies, and advanced biologic therapies
- Cell and gene therapy manufacturing
- Nanotechnology in therapeutic delivery
- Regulatory challenges and quality assurance in biopharmaceuticals
Commitment to Excellence
IJBMTA upholds the highest standards of scientific rigor and integrity. Every submission undergoes a double-blind peer review to ensure credibility, accuracy, and relevance. We are committed to supporting authors throughout the editorial process and promoting the global dissemination of impactful research.
Whether you are an early-career researcher, experienced academic, or industry professional, IJBMTA offers a trusted platform to publish, discover, and collaborate on innovative biopharmaceutical solutions for the future of healthcare.
